Purchase Order 75N95020P00733
- Not listed
- The National Center for Advancing Translational Sciences (NCATS), a civilian agency, awarded a $75,735 firm fixed price purchase order to Genewiz, LLC, a subsidiary of Azenta, Inc., for whole genome sequencing services on 27 human induced pluripotent stem cells (iPSCs) in different cell derivatives. This work was not set aside for any particular business type. Genewiz has held several Indefinite Delivery/Indefinite Quantity (IDIQ) contract vehicles with federal agencies including the National...
- The Department of Health and Human Services National Institutes of Health National Institute of Environmental Health Sciences awarded a $30,000 firm fixed price delivery order to Genewiz, LLC, a subsidiary of Azenta, Inc., for DNA sequencing services. The contract has no set-aside designation and requires the sequencing work be completed by November 26, 2024 at the contractor's place of performance in Morrisville, North Carolina. As the award is for DNA sequencing services and was issued by...
- This federal contract award to Genewiz, LLC, a global contract research organization, was made by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH). The $5,300.00 firm fixed price purchase order is for other functions - whole genome sequencing of 8 samples. The award has no set-aside designation. Through this contract, Genewiz will provide specialized genomic services, including next-generation sequencing, to support research...
- The U.S. Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a firm fixed-price purchase order to Genewiz, LLC, a global contract research organization specializing in genomic services. The $37,046.85 contract is for gene synthesis, custom cloning, and variant synthesis. Genewiz has provided DNA and RNA sequencing, bioinformatics, and other genomic services to federal agencies such as the NIH, NCI, VA, and USGS...
- Genewiz, LLC, a global contract research organization specializing in genomic services, was awarded a firm fixed price purchase order valued at $5,390.00 by the Plains Area civilian federal agency for whole genome genetic sequencing services. The contract, issued on April 19, 2017, with an ultimate completion date of June 19, 2017, represents a focused engagement for Genewiz's core competency in next-generation sequencing and genomic analysis. The work is to be performed at Genewiz's facility in...
- On September 10, 2020, the National Institute on Drug Abuse (NIDA) awarded a $20,794.57 firm fixed-price purchase order to Genewiz, LLC for single cell RNA sequencing analysis of human induced pluripotent stem cells (iPSCs). The performance period ran from September 10, 2020 through September 9, 2021, with work performed in South Plainfield, New Jersey. No small business set-aside was applied to this contract. Genewiz, a global contract research organization and subsidiary of Azenta, Inc.,...
- This is a firm-fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Genewiz, LLC, a global contract research organization specializing in genomic services. The $7,481.25 contract is for AMBIS # 1723756 SEQUENCING services, which likely includes DNA and RNA sequencing, library preparation, and bioinformatics analysis. Genewiz has provided similar sequencing services to support research...
- The U.S. government awarded a $24,080 firm fixed-price purchase order to Genewiz, LLC for DNA sequencing services. The contract was executed on May 23, 2017, with an ultimate completion date of July 31, 2017, and is being performed in South Plainfield, New Jersey. This award to the genomic services contractor carries no set-aside designation and represents work directly supporting a civilian federal agency through its Midwest Area office. Genewiz, LLC, a global contract research organization and...
- This is a firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Genewiz, LLC, a global contract research organization specializing in genomic services. The $9,900.00 contract is for RNA library preparation, with a completion date of June 27, 2014. Genewiz has provided DNA and RNA sequencing services to support research initiatives at various federal agencies under past contract awards,...
- This federal contract award to Genewiz, LLC, a global contract research organization, is for SEQUENCING SERVICE with the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH). The $93,600.00 firm fixed price contract was awarded on a sole source basis under FAR 6.302-1 due to Genewiz's unique capabilities to meet the salient requirements of the research trial. The contract was not set aside and is part of Genewiz's existing federal...
The Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences awarded a $345,333 firm fixed price purchase order to Genewiz, LLC for whole genome sequencing services using 90 human induced pluripotent stem cell samples. The solicitation sought these sequencing services to be performed within 45 days of sample receipt in September 2020. Genewiz will conduct the work at its facility in South Plainfield, New Jersey as the incumbent contractor able to continue research using the same sequencing platform and techniques for continuity of science. There was no set-aside designation for this award made under NAICS code 541380 to support the National Center's research and development in physical, engineering, and life sciences.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Whole genome sequencing services using 90 human iPSC samples | 75N95020Q00280 | Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse | Solicitation 1/2 | 8/31/20, 3:29 PM | |
Whole genome sequencing services using 90 human iPSC samples | 75N95020Q00280 | Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse | Award Notice 2/2 | 10/1/20, 3:47 PM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Supplemental Agreement for work within scope | ($25k) | 12/8/21 | |
| Not listed | Not listed | $370.0k | 9/24/20 |